Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Boceprevir Anemia Management in Chronic Hepatitis C
NCT01023035Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Dec 2009
- Primary completion
- Oct 2011
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of boceprevir in hepatitis C (HCV), sponsored by Merck & Co.. Started Dec 2009; status: completed.
02
Drugs
boceprevir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01023035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01023035.